MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 161 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2014. The put-call ratio across all filers is 4.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $100,000 | -10.7% | 5,859 | -2.8% | 0.01% | -14.3% |
| Q2 2015 | $112,000 | +8.7% | 6,025 | +11.1% | 0.01% | +16.7% |
| Q1 2015 | $103,000 | +10.8% | 5,423 | -3.5% | 0.01% | 0.0% |
| Q4 2014 | $93,000 | +10.7% | 5,620 | +18.7% | 0.01% | 0.0% |
| Q3 2014 | $84,000 | -6.7% | 4,736 | +9.1% | 0.01% | 0.0% |
| Q2 2014 | $90,000 | +11.1% | 4,339 | +17.0% | 0.01% | 0.0% |
| Q1 2014 | $81,000 | +2.5% | 3,707 | +24.8% | 0.01% | 0.0% |
| Q4 2013 | $79,000 | +36.2% | 2,970 | +20.7% | 0.01% | 0.0% |
| Q3 2013 | $58,000 | +23.4% | 2,461 | +13.4% | 0.01% | +20.0% |
| Q2 2013 | $47,000 | +9.3% | 2,171 | +14.4% | 0.01% | 0.0% |
| Q1 2013 | $43,000 | +38.7% | 1,898 | +22.5% | 0.01% | +25.0% |
| Q2 2012 | $31,000 | -24.4% | 1,550 | -26.5% | 0.00% | -20.0% |
| Q1 2012 | $41,000 | +41.4% | 2,109 | +40.2% | 0.01% | +25.0% |
| Q4 2011 | $29,000 | +7.4% | 1,504 | -8.2% | 0.00% | 0.0% |
| Q3 2011 | $27,000 | – | 1,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |